🗓️2025 Year-End Data Closeout and Reconciliation
It’s data closeout season again! Mark your calendars with these key dates:
-
December 2025: Preliminary data closeout line lists will be sent to LHJ partners to get a head start on data cleanup.
-
December 31, 2025 (by noon): Deadline to submit all cases for counting in 2025.
-
January 16, 2026: Limited provisional variables due for all 2025 cases.
-
February 2, 2026: Double check that contact identification data for all 2024 cases has been entered into WDRS (this allows them to be included in data cleanup).
-
Early February 2026: Second round of data closeout line lists sent out.
-
March 6, 2026: Final data deadline.
- Case data must be as complete as possible for 2025 cases.
- Contact identification data for 2024 cases must be as complete as possible
- Class B screening data should be as complete as possible.
This information and other resources are available on the TB Data Resources SharePoint page. Email tbservices@doh.wa.gov with any questions or concerns or to request access to the SharePoint.
🗓️Targeted Testing Project Reminders
Targeted testing for TB is a strategy to diagnose and treat Latent TB Infection (LTBI) among people who are at high or increased risk for developing TB disease. Targeted testing is crucial for TB elimination; by focusing on these high-risk groups, targeted testing can prevent the progression of LTBI to active TB disease and reduce the overall incidence of TB in the community. Targeted testing activities also save public health funds in the long-term; reaching people early in the disease continuum is cheaper and less disruptive to their lives compared to diagnosing and treating active TB disease.
We encourage all LHJs to consider how they might collaboratively reach groups at higher risk for TB in their communities for screening and evaluate potential partner organizations for targeted testing work.
Only 2 new targeted testing deliverables remain for LHJs receiving 2025 DOH TB funding through the Consolidated Contract (ConCon):
-
Due January 31, 2026 is the Annual ConCon Deliverables Report. Early in January, your LHJ TB manager will be sent a reminder with an example template and last year's Report.
-
Due by the first week of February are any targeted testing data (line-level or aggregate). These data will be aggregated and reported to CDC partners.
A targeted testing resources section will be coming soon to the TB Partners SharePoint, including templates for reporting targeted testing data.
📝Please Complete the TB Workforce Assessment
On November 21st, the DOH TB Program distributed to each LHJ TB point of contact a voluntary TB workforce assessment requesting completion on or before December 22nd. To date, excluding the Public Health Laboratory and the DOH TB Program, 6 responses have been received. Additional details about the assessment are below and although participation is voluntary, we strongly encourage each LHJ to capture their anticipated future TB needs.
The US Centers for Disease Control and Prevention (CDC) TB Elimination and Laboratory Cooperative Agreement awardees, which include WA, are required to undertake this TB workforce assessment. An Excel file was distributed aiming to capture each unique LHJ's current and future anticipated TB staffing needs, so the cooperative agreement requirement could be met. The TB workforce assessment captures the number of "current" (as of 11/15/25) positions working in any capacity in TB, the percentage of time dedicated to TB, and the federal versus non-federal funding percentage of each position. Detailed budget information is not collected. The assessment then attempts to capture any additional "desired" positions (i.e., nurses, clinicians, epidemiologists, laboratorians, health educators, etc.) the LHJ would need to implement robust TB elimination activities.
Although the distributed workforce assessment Excel template file includes fields that capture LHJ and DOH-level staffing information (e.g., names), no identifying information will be submitted to the CDC. Any collected data will be aggregated to the state level only and will be submitted to CDC in a narrative-style report. To protect LHJ-level data and to promote appropriate data minimization, the narrative will not contain any details about current or desired TB staffing at a geographic level smaller than Washington state. CDC will not have direct access to Washington's TB workforce assessment data, just the high-level, narrative report. Additionally, each LHJ has the option to remove identifying information entered into the Excel template, prior to returning completed assessments to the DOH TB Program.
Completed TB workforce assessments can be returned via email to us at tbservices@doh.wa.gov or to Scott.Hutton@doh.wa.gov. Questions about the workforce assessment can be directed to Scott via the email address above or by calling 564-200-3178.
We appreciate any time dedicated to completing and returning the assessment.
🤝Thank you for Participating in Fall TB Cohort Review
Thank you to the LHJs who participated in one-on-one Cohort Reviews with the DOH TB Program. We greatly appreciate your partnership and hope your teams found value in reviewing TB surveillance and NTIP data.
This year’s Cohort Reviews focused on the following NTIP indicators:
-
Known HIV Status: Increase the proportion of TB patients with a positive or negative HIV test result reported.
-
Treatment Initiation: For TB patients with positive acid-fast bacillus sputum-smear results, increase the proportion who initiated treatment within 7 days of specimen collection.
-
Sputum Culture Conversion: For TB patients with positive sputum culture results, increase the proportion with a documented conversion to negative results within 60 days of treatment initiation.
-
Genotyping: For TB patients with a positive culture result, increase the proportion who have a genotyping result reported.
We are currently identifying and summarizing key takeaways from the 2025 Cohort Review sessions and will share a full report in the new year. In the meantime, you can view the 2024 Cohort Review Report.
Thank you again to everyone who participated this year. If you have feedback on our Cohort Review model, please contact us at tbservices@doh.wa.gov.
🔔SureAdhere Reminders and Updates
As we approach the end of the year, it’s a great time for LHJs with SureAdhere access to review both staff and patient accounts.
- For patients who have completed or otherwise stopped treatment, simply uncheck the "Account is active" box on the patient's "Profile" tab. This will remove the patient from your Dashboard.
- If you need to update staff roles or deactivate accounts, please contact tbservices@doh.wa.gov.
- Have you noticed recent changes in the SureAdhere provider or patient applications? Be sure to check the latest updates in the SureAdhere Release Notes.
|
|
 |
💊Waste TB Medications?
Please remember to report any medications obtained by your LHJ from the DOH TB Program that your program had to dispose of. We request that you submit this information at least quarterly or as each situation arises. Send an email to tbservices@doh.wa.gov with the following details:
- Medication type (e.g., rifampin, isoniazid, etc.)
- Dosage (e.g., 100 mg, 300 mg, etc.)
- Number of pills that will be or were disposed of
- Which program order form was used (340B, MMCAP, or Former CDC Stockpile)
- Reason for disposal (e.g., expiration)
Note: Unopened bottles of medications can be returned to the pharmacy if you know your LHJ will not use them. Please do not return medications that are within 30 days of expiration.
If you have any questions, feel free to reach out to us by email.
|
